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ineffective.[1] In recent years, stem cell therapy has been 
considered as an effective method of  tissue regeneration.[2] 
Mesenchymal stem cells (MSCs) are stromal cells that ex-
hibit the characteristics of  self-renewal and multi-lineage 
differentiation[3] and which have been accepted as a promis-
ing cell source in tissue repair and regeneration.[4] Studies 
have shown that during wound repair, ischemia or cancer 
invasion, MSCs mobilize to the circulation, recruit to the 
injury site and promote tissue repair.[5,6] However, the stem 
cells that are recruited to the wound site for tissue regenera-
tion are insufficient.[7] As a result, broader mobilization and 
recruitment of  MSCs specifically to the injury site has been 
a major area of  study.
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A B S T R A C T
 Mesenchymal stem cells (MSCs) have been accepted as a promising cell source in tissue repair and regeneration. However, the inabil-
ity to enrich MSCs in target areas limits their wide application. As a result, it has been a major goal to induce MSCs to be abundantly 
and specifi cally recruited to the injury site. In this study, a peptide with a specifi c aﬃ  nity for MSCs (E7 peptide) was immobilized to a 
collagen scaﬀ old via a collagen-binding domain (CBD) to construct a functional collagen scaﬀ old. In addition, the hypothesis that this 
method could recruit MSCs specifi cally was evaluated in a porcine model. In vivo investigations indicated that due to the immunore-
action, the CBD-MSC-peptide collagen scaﬀ old enhanced MSC adhesion and infi ltration and promoted wound healing. At day 7 after 
surgery, we found more infi ltrating cells and capillaries in the Collagen/CBD-E7 peptide group compared to the Scaﬀ old group. At 
day 14, 21 and 28, a faster healing process was observed in the Collagen/CBD-E7 peptide group, with signifi cant diﬀ erences compared 
with the other groups (P < 0.05, P < 0.01). The results demonstrate the potential use of targeted therapy to rapidly heal skin wounds.
Key words:  Mesenchymal stem cells, skin wound healing, Collagen-binding domain, mesenchymal stem cells aﬃ  nity peptide
 Introduction
 Massive full-thickness wounds caused by extensive burns 
or high-energy trauma are common in the clinical, but 
treatment for these emergencies is limited and largely 
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Recently, a novel peptide (E7 peptide, “EPLQLKM”) was 
reported to have high, specific affinity to MSCs. When co-
valently conjugating to a synthetic polycaprolactone (PCL) 
mesh, this peptide significantly mobilized and recruited 
autologous MSC to PCL in vivo.[4] Compared to synthetic 
materials, collagen has commonly been used in wound re-
pair and skin regeneration due to its weak antigenicity and 
excellent biocompatibility.[8] Binding of  a specific stem cell 
affinity protein to a biomaterial has also successfully been 
applied to the regeneration of  damaged myocardium.[6]
However, few studies have put such a method to use in the 
treatment of  massive full-thickness wounds.[9]
As described previously, the collagen-binding domain (CBD) 
shows great affinity to collagen I and can maintain growth 
factor activity both in vitro and in vivo.[10,11] To this end, we 
produced a fusion protein (CBD-MSC-peptide) consisting 
of  the MSC affinity peptide (MSC-peptide) and a CBD. This 
protein was able to specifically bind to collagen I and allowed 
the MSC-peptide to bind to collagen. We hypothesized that 
due to the immune reaction induced by the scaffold, MSC 
cells would migrate to the target region and promote both 
wound healing and skin regeneration. The hypothesis was 
evaluated in a porcine full-thickness defect model.
Materials and methods
Preparation of collagen/CBD-E7 peptide functional scaffolds
The collagen membrane was prepared as described previ-
ously.[6] It was cut into 5.0 × 5.0 cm squares with a thickness 
of  1.0 mm [Figure 1a]. CBD-E7 peptides were synthesized 
through solid-phase peptide synthesis using Fmoc Chemistry 
(Scilight-Peptide Inc., Beijing, China). Next, 250 μg of CBD-
E7 peptides were dissolved in 100 μl phosphate-buffered 
saline (PBS) and added to the collagen  membrane. The 
surface morphology of  the collagen scaffold before and after 
treatment was observed by scanning electron microscopy 
(SEM) (model S-2500, Hitachi, Japan) [Figure 1b and c].
Animal models
Six domestic pigs weighing between 20 and 25 kg were used 
for implantation. There was no injection of granulocyteolony 
stimulating factor (G-CSF) before the skin defect model was in-
duced. After the administration of anesthesia by propofol, the 
dorsal hair was shaved. Six full-thickness wounds (3 incisions 
on each side, 5.0 × 5.0 cm) were made on the dorsum down to 
the level of subcutaneous deep fascia, and different collagen 
membranes were affixed to the defects with 4-0 silk suture.
Total 36 wounds were randomly divided into 3 groups: A 
control group (Control, n = 2 × 6), a collagen group (Col-
lagen, n = 2 × 6), and a Collagen/CBD-E7 peptide group 
(Collagen/CBD-E7 peptide, n = 2 × 6).
After the operation, the pigs were housed in separate cages. 
All animals received intramuscular penicillin for 3 days after 
surgery. All of the pigs survived during the experiments. All of  
the animals and experimental procedures were approved by the 
local Institutional Animal Care committee. Chinese Ministry 
of Public Health (CMPH) guidelines for the care and use of  
laboratory animals were abided by during all experiments.
Analysis of cells on the material
Three days after the surgery, 3 animals were sacrificed. 
Samples of  the material were removed, and a portion of  the 
membranes (1.0 × 1.0 cm) were excised for  cell infiltration 
analysis. The cells retained on the collagen were stained 
with Hoechst 33342 (2 mg/ml, Sigma, USA) for 15 min. 
After washing them three times, photos were taken.
Part of  the deep fascia (1.0 × 1.0 cm) that included the 
collagen membranes was excised. After fixation in 10% for-
malin, 5 μm paraffin sections were stained by hematoxylin 
and eosin (HE) for analysis of  the inflammatory reaction 
and cell infiltration.
In a separate experiment, the remaining collagen was digest-
ed using collagenase type I, and the cells that were retained 
on the materials were collected. The cells were cultured in 
standard liquid culture medium containing DMEM-F12, 
10% FBS, 100 U/ml penicillin, 100 mg/ml streptomycin 
at 37° C in a 5% CO2 atmosphere to the second passage. 
Then, the cells were prepared for fluorescence activated cell 
sorting (FACS) analysis to determine whether the materials 
were enriched in cells that with stem cell characteristics.
Figure 1: Collagen scaffold morphology. (a) Macroscopic view of the 
collagen scaffold; (b) Scanning electron microscopy (SEM) image of the 
collagen scaffold. Scale bar =100 μm; (c) SEM image of the collagen 
scaffold conjugated with E7 peptide. Scale bar =100 μm.
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Measurement of healing rate in a porcine model
The wound area was examined and photographed by digital 
camera (Canon EOS 550D) on day 7, 14, 21 and 28 post-
surgery. The area of  the unhealed wound was measured 
using Photoshop software in order to calculate the healing 
rates (Adobe Photoshop 7.0). The following equation was 
used: Healing rate = [(original size - non-healing area)/
original area] ×100%.[11]
Vascularization evaluation
At day 7 after operation, a portion of  the wound samples 
(1.0 × 1.0 cm) that included the materials was excised. After 
fixation in 10% formalin, 5 μm paraffin sections were stained 
with HE, and immunohistochemical (IHC) analysis was 
performed for analysis of  cell proliferation and blood vessel 
formation. An anti-von Willebrand factor antibody (vWF, 
1:800, Abcam, USA) was used to evaluate the degree of  
vascularization in the wound granulation tissues. Two inde-
pendent observers quantified the number of blood vessels for 
each section, and counts were made for six random selected 
areas at 200× magnification level in a blinded fashion.
Statistical  analysis
Statistics were calculated with SPSS computer software 
for Windows (version 13.0, SPSS Inc., Chicago, IL). The 
values were expressed as means ± standard deviation (SD). 
Significant differences between the groups were determined 
by one-way analysis of  variance (ANOVA). The least-
significance-difference method (LSD) or Tamhane’s T2 test 
was used for post-hoc multiple comparisons for equal or 
unequal variances. A probability value (P) of  less than 0.05 
was considered to be statistically significant. Statistically 
significant values were defined as *P < 0.05 and **P < 0.01.
Results
The collagen scaffold
The structure of  the collagen scaffold was observed by 
SEM. Figure 1b and c show the appearance of  collagen 
scaffold before and after treatment with E7 peptide. When 
conjugated with the E7 peptide, the interconnected pores 
of  collagen scaffold were mostly filled.
Cell analysis of collagen scaffolds
At day 3 post-surgery, a portion of the materials was removed, 
and there were significantly more cells retained on the CBD-
E7 collagen scaffold than on collagen scaffold [Figure 2a]. A 
greater number of cells were recruited to the deep fascia in the 
Collagen/CBD-E7 peptide group, whereas in the Collagen 
group, the distribution of  the cells was sporadic [Figure 2b].
Figure 2: Cellularization of collagen scaffolds. (a) Hoechst 33342 
staining of the cells retained on the collagen with different treatments; 
(b) Cellular distribution in the deep fascia. The number of the cells 
infi ltrated in the deep fascia in the collagen-binding domain (CBD)/
peptide group was signifi cantly higher than that in the Scaffold group 
(per fi eld); (c) Histological evaluations of specimen tissues implanted 
with collagen scaffolds (left) and collagen/CBD-E7 peptide at day 7 
post-surgery. The black curve shows the border between the material 
and the granulation tissue. (hematoxylin and eosin stain, ×200). (d) Cells 
derived from CBD-E7 Collagen scaffold at day 3 exhibit characteristic 
phenotypes of Mesenchymal stem cells (MSCs) (fi broblast-like growth 
and clumped together in a “swirl” pattern). (e) Fluorescence activated cell 
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At 7 day after surgery, a sample of  granulation tissue with 
the tested materials was removed and evaluated by HE 
staining. The scaffold appeared similar to collagen fiber, 
and more cells had infiltrated in the Collagen/CBD-E7 
peptide group [Figure 2c].
The cells enriched on the collagen that were to be used for 
culture analysis were obtained by digesting the remaining 
collagen. Three days later, these cells exhibited fibroblast-
like growth and clumped together in a “swirl” pattern at 
day 7 [Figure 2d].
The cultured cells were obtained for molecular phenotype 
analysis. As demonstrated in Figure 2e, the cells were identi-
fied as CD45 negative, CD29 positive and CD44 positive, 
and thus were characterized as MSCs.
Wound healing rate 
Seven days after surgery, the healing rates of  the 3 groups 
were not significantly different (P > 0.05). However, after 
14 days of  treatment, the Collagen/CBD-E7 peptide group 
showed the highest rate of  healing among the 3 groups (P < 
0.05, P < 0.01). Moreover, a significantly more rapid wound 
healing process was observed in Collagen/CBD-E7 peptide 
group at day 21 and 28 than was found for the other groups (P 
< 0.05, P < 0.01) [Figure 3]. In addition, the wound-healing 
rate was significantly higher in the Collagen group compared 
to the control group after 14 days (P < 0.05).
Angiogenesis induction by the collagen/CBD-E7 peptide 
scaffold
Capillaries were detected by immunostaining using an 
anti-vWF antibody. In wound granulation tissue, the 
capillary density in the Collagen/CBD-E7 peptide group 
(78.70 ± 8.77) was significantly higher than that of  Collagen 
(58.35 ± 5.03) and control groups (37.30 ± 6.73) [Figure 4b 
and c], which was consistent with the evidence provided by 
HE staining [Figure 4a]. It has been shown that the infiltra-
tion and migration of  cells, especially endothelial cells, are 
Figure 3: Wound size measurements at different time points. (a) The 
appearances of the wounds in the different groups at day 0, 7, 14, 21 
and 28; (b) The statistical analysis of the healing rate in the different 
groups. 7 d: Collagen/CBD-E7 peptide: 3.96 ± 1.9%, Collagen: 3.15 ± 
3.3%, Control: 2.52 ± 3.1%; 14 d: Collagen/CBD-E7 peptide: 67.04 ± 
4.8%, Collagen: 59.11 ± 2.7%, Control: 56.76 ± 4.3%; 21 d: Collagen/
CBD-E7 peptide: 90.96 ± 2.7%, Collagen: 82.96 ± 1.92%, Control: 
77.98 ± 2.8%; 28 d: Collagen/CBD-E7 peptide: 96.90 ± 2.3%, Collagen: 
92.05 ± 1.6%, Control: 86.93 ± 3.1%. The data are presented as the 
mean ± SD. **P < 0.01, *P < 0.05. CBD = collagen-binding domain. 
SD = standard deviation.
a
b
Figure 4: Hematoxylin and eosin (HE) and immunohistochemical 
(IHC) staining for capillary vessel formation in skin wounds 7 days after 
surgery (n = 6). (a) HE staining. (b) The degree of vascularization in the 
wound granulation tissues. The arrows indicate blood vessels. (c) The 
statistical analysis of the blood vessel density. The data are presented 
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important for angiogenesis.[12] It is possible that a subset of  
the endothelial cells or hematopoietic stem cells could also 
be enriched at target site, increasing blood vessel formation 
around the wound, improving blood perfusion, and thereby 
accelerating the wound healing process.
Discussion
Wound healing is one of  the basic problems in the surgical 
field, lacking effective clinical treatment. In most patients, 
partial skin loss can be managed by closure with remaining 
local skin[13]; however, for patients with extensive full-thick-
ness injury more than 4 cm in diameter, the incomplete skin 
cannot regenerate itself  spontaneously without a graft.[14]
Stem cell therapy has emerged as a potential therapeutic 
strategy for full-thickness wound repair.[2] Autologous MSCs 
are among the most promising cell types, exhibiting the 
characteristics of  self-renewal, multi-lineage differentiation 
and low immunogenicity.[3] Long-term studies have shown 
that the perivascular niche could be a location in which 
MSC-like cells reside.[15,16] Although MSCs can migrate to 
the injury sites during wound repair, ischemia or cancer 
invasion, the cells that are recruited for tissue regeneration 
are insufficient.[17]
In this study, we hypothesized that the Collagen/CBD-E7 
peptide group could recruit MSCs in vivo. Furthermore, it 
was proposed that the functional scaffold could promote 
overall wound repair when used to treat of  skin injury. At 
day 3 in vivo, the cell numbers in the designed material and 
deep fascia reflected the early tendency of  cell migration 
and the biocompatibility of  the scaffold [Figure 2a and 
b]. We deduced that Collagen/CBD-E7 peptide could 
enhance the recruitment of  stem cells to the scaffold and 
that the scaffold provided a proper environment for cell 
survival and the subsequent cascading injury response. As 
is well known, neovascularization is an essential step in 
the complicated wound healing process.[2] At day 7 after 
surgery, we found more cells and capillaries infiltrated 
in the Collagen/CBD-E7 peptide group compared to the 
Collagen group.
At day 7, 14, 21 and 28 post-surgery, the wound area was 
examined and photographed for wound healing analysis. 
Seven days after surgery, the healing rate between the 
three groups showed no statistically significant difference 
(P > 0.05) [Figure 3]. We deduced that the stem cells did 
not exhibit their pluripotent potential in this early part of  
the process. Subsequently, more rapid healing of  wounds 
was observed in the Collagen/CBD-E7 peptide group at 
day 14, 21 and 28 post-surgery, with significant difference 
with the other groups (P < 0.05, P < 0.01) [Figure 3]. This 
result indicated that the mobilized MSCs could migrate to 
the scaffold, shorten the healing time and improve wound 
repair via their multi-lineage differentiation capabilities. 
Moreover, the 3D collagen scaffold, which was also im-
portant for the survival and function of  the stem cells in 
the injury sites, might facilitate cell-scaffold interactions, 
including migration, proliferation and differentiation.
The MSCs’ specific affinity for the E7 peptide has been 
successfully used in MSC-homing research.[4] These stud-
ies have revealed that the specific binding of  E7 to MSCs 
could induce autologous MSC recruitment in response to 
trauma or ischemia. A suitable microenvironment is also 
important for cell migration and tissue regeneration.[2] Col-
lagen is regarded as one of  the most useful biomaterials 
for its excellent biocompatibility and biodegradability, and 
it is widely used in tissue engineering.[11] As is shown in 
Figure 1b and c by SEM, the collagen scaffold was porous 
before treatment. When conjugated with the MSC-binding 
E7 peptide, the interconnected pores were generally filled, 
which was important for cell immigration.
It has been considered that CBD technology has the advan-
tage of  both durability and specificity. In this study, using the 
collagen scaffold to bind E7 peptide, which has a specific af-
finity for MSC, resulted in the capture of  autologous MSCs 
and the acceleration of  injured tissue vascularization. As 
is shown in Figure 4, the blood vessel density in the Col-
lagen/CBD-E7 peptide group was much higher than in the 
other groups. We concluded that the bio-composite could 
promote vascularization and, thereby, the subsequent rapid 
tissue regeneration. As is well known, MSCs are positive 
for CD29, CD90, CD44, and CD105 but negative for CD34 
and CD45.[3,7] In this study, adhered cells on the scaffolds 
were characterized as MSCs (CD45-, CD29+, CD44+), as 
were verified by FACS. The results indicated that MSCs 
played a significant role in promoting wound healing and 
skin regeneration.
Although the Collagen/CBD-E7 peptide scaffold was effec-
tive in MSC recruitment and wound healing, certain limita-
tions remained. First, more samples should be investigated. 
Second, the E7 peptide (“although the Collagen/CBD-E7 
peptide scaffold was effective in MSC rein rabbit models, in 
which it significantly enhanced autologous MSC recruitment.
[4] In this study, we constructed an E7 peptide-based function-
al collagen scaffold to recruit autologous MSCs in a porcine 
skin model for wound healing at porcine models. No immune 
rejection and risk of  tumor was observed; however, further 
studies are required to confirm the clinical efficiency and 
safety profile of  this capture system. Lastly, further  research 
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is needed on skin and cutaneous appendages regeneration. 
Taken together, these data provided new insights for the 
treatment of acute full-thickness wounds by cellular-material 
therapy and should contribute to new strategies for the treat-
ment of  chronic wounds and ischemic diseases.
Conclusion
In this work, collagen scaffolds that were functionalized 
with a peptide with a specific affinity for MSCs were used in 
a porcine wound-healing model. After implantation at the 
injured skin, the functional scaffold effectively enhanced the 
recruitment of MSCs, accelerated the healing rate and pro-
moted neovascularization. This study provided new insights 
for enriching autologous stem cells to the wound site and con-
tributed to new methods for the treatment of wound healing.
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